Treatment of acute hepatitis C virus infection

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 189-192

  Voge, Wolfgang ^a,b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b NONE   (Austria)

Author keywords

Acute hepatitis C; HCV; Interferon; Meta analyses

Indexed keywords

ALANINE AMINOTRANSFERASE; BETA INTERFERON; HEPATITIS C ANTIBODY; INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ACUTE HEPATITIS; AMINOTRANSFERASE BLOOD LEVEL; CHRONICITY; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DRUG RESPONSE; HEPATITIS C; HUMAN; META ANALYSIS; PRIORITY JOURNAL; VIRUS LOAD;

ACUTE DISEASE; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; VIRAL LOAD;

EID: 0033429089     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994: 23: 427-435.
2. Barrera JM, Bruguera M, Guadalupe-Ercilla M, Gil C, Celis R, Gil MP et al. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 1995: 21: 639-644.
3. Quinti I, el-Salman D, Monier MK, Hackbart BG, Darwish MS, el-Zamiaty D et al. HCV infection in Egyptian patients with acute hepatitis. Dig Dis Sei 1997: 42: 2017-2023.
4. Quin JW. Interferon therapy for acute hepatitis C viral infection a review by meta-analysis. Aust NZ J Med 1997: 27: 611-618.
5. Camma C, Almasio P, Craxi A. Interferon as treatment for acute hepatitis C. A Meta-analysis. Dig Dis Sei 1996: 41: 1248-1255.
6. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P et al. Meta-analysis of Interferon randomized trials in the treatment of viral hepatitis C: effect of dose and duration. Hepatology 1996: 24: 778-789.
7. Vilademiou L, Genesca J, Esteban J et al. Interferon-or in acute post transfusion-hepatitis C: a randomised controlled trial. Hepatology 1992: 15: 767-779.
8. Tassopoulos NC, Koutelou MG, Papatheodoridis G et al. Recombinant human Interferon alpha-2b treatment for acute nonA, non-B hepatitis. Gut 1993: S130-132.
9. Lampertico P, Rumi M, Romeo R et al. A multicenter randomized controlled trial of rccombinant interferon-or2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994: 19: 19-22.
10. Li XW. A report on the therapy of interferon a-2b in patients with acute hepatitis. Chin J Inter Med 1993: 32: 409-111.
11. Genesca J, Esteban JI, Quer J et al. Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon-2b. Gut 1993: S62-63.
12. Hwang SJ, Lee SD, Chan CY, Lu RH, Lo KJ et al. A randomized controlled trial of recombinant interferon-a2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 1994: 21: 831-836.
13. Palmovic DI, Kurelac I, Crnjakovic-Palmovic J. The treatment of acute post transfusion-hepatitis C with recombinant interferon-2b. Infection 1994: 22: 222-223.
14. Alberti A, Chemello L, Belussi F et al. Outcome of acute hepatitis C and role of alpha interferon therapy. Viral Hepat Liver Dis 1994: 604-606.
15. Vogel W, Graziadei I, Umlauft F et al. High-dose interferon-cr2b treatment prevents chronicity in acute hepatitis C. A pilot study. Dig Dis Sei 1996: 41: 81S-85S.
16. Omata M, Yokosuka O, Takano S et al. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991: 338: 914-915.
17. T akano S, Satomura Y, Omata M and Japan acute hepatitis cooperative study groups. Effects of interferon beta on non-A, nonB hepatitis: a prospective, randomized, controlled-dose study. Gastroenterology 1994: 107: 805-811.
18. Calleri G, Colombatto M, Gozzelini M, Chieppo F, Romano P, Delmastro B et al. Natural beta interferon in acute type-C hepatitis patients: a randomised controlled trial. Ital J Gastroenterol Hepatol 1998: 30: 181-184.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986: 7: 177-188.